about
Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell...
Read More
2.44
-0.04
(-1.61%)
54,521
XNAS Volume
XNAS 11 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Mural Oncology plc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..